HRSA-22-086: Autism Single Investigator Innovation Program (Autism-SIIP) – Autism Longitudinal Data Project (ALDP)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants of up to $500,000 to nonprofits, colleges and universities, state and local governments and tribes. It expected to make one award worth $500,000 in total. Applications closed on April 4, 2022.
From the official notice on Grants.gov, last changed January 4, 2022. Checked November 7, 2026.
- Award ceiling$500,000
- Total funding$500,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | January 4, 2022 |
|---|---|
| Deadline | April 4, 2022 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
All 10 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include any domestic public or private entity, including research centers or networks. Domestic faith-based and community-based organizations, tribes, and tribal organizations are eligible to apply.
Is this a realistic fit?
- Past Autism Collaboration, Accountability, Research, Education, and Support awards averaged $981,155; this notice allows up to $500,000 per award.
- No cost sharing or match is required.
What the grant funds
The HRSA-22-086: ALDP supports the implementation and completion of research that leverages existing longitudinal data resources and evaluates the effect of early interventions using observational studies/secondary data to improve our understanding of the early life origins, signs, and indicators of ASD/DD and its comorbidities. Applicants to the HRSA-22-086: ALDP will conduct research on topics of interest to HRSA’s Maternal and Child Health Bureau (MCHB), including studies that build on our current knowledge base and leverage existing longitudinal data analyses to: • Study genetic and environmental maternal and perinatal contributing and/or predictive factors for ASD/DD; • Consider physical and behavioral trajectories of ASD/DD and assessment at different stages of life course development; • Explore primary prevention of ASD/DD; Study the effects of various ASD/DD interventions using observational studies/secondary data; and • Promote greater national and public awareness of the early life origins, signs, indicators, and interventions for ASD/DD and its comorbidities by providing leadership in the dissemination of findings from ALDP research.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before
From fiscal 2021 to 2025, Autism Collaboration, Accountability, Research, Education, and Support (93.877) awarded $103 million across 105 grant awards, an average of $981,155 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of California, Los Angeles | California | 6 | $8.5 million |
| The Children's Hospital of Philadelphia | Pennsylvania | 4 | $3.5 million |
| University of Wisconsin System | Wisconsin | 3 | $3.4 million |
| University of California, Davis | California | 3 | $2.8 million |
| The Regents of the University of Colorado | Colorado | 2 | $2.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-086 still open?
No. It closed on April 4, 2022.
Who can apply for Autism Single Investigator Innovation Program (Autism-SIIP) – Autism Longitudinal Data Project (ALDP)?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Autism Single Investigator Innovation Program (Autism-SIIP) – Autism Longitudinal Data Project (ALDP)?
Closed April 4, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $500,000 in total for one award.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before?
The largest recipients over five fiscal years were University of California, Los Angeles, The Children's Hospital of Philadelphia, University of Wisconsin System. The program made 105 awards worth $103 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)